You are a helpful, respectful, and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information.
What is Laboratory monitoring of which of the following is desirable with low molecular weight heparin therapy in a patient with renal failure? and explain in detail?
LMW heparin and fondaparinux have long half lives and consistent SC absorption; therefore do not require monitoring and once daily SC doses are sufficient. Patients with end stage renal failure and morbid obesity may require monitoring with anti-factor Xa assay.